Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Your research
Country: Israel,Australia,India,Russian Federation,Italy,France,Belarus,China,Hungary,United States
nct
Update Il y a 5 ans
FUTURE 3 Study Extension
The objectives of the FUTURE 3 Study Extension are to evaluate the long-term safety, tolerability and efficacy of the pediatric formulation of bosentan two versus three times a day in children with Pulmonary Arterial Hypertension (PAH).
Country
Australia
,
Belarus
,
China
,
Czech Republic
,
France
,
Germany
,
Hungary
,
India
,
Israel
,
Italy
,
Mexico
,
Netherlands
,
Poland
,
Russian Federation
,
Serbia
,
South Africa
,
Spain
,
Ukraine
,
United States
,
organs
None
Specialty
None
Closed trial
More information
nct
Update Il y a 5 ans
Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension
The primary objective of AC-052-373 was to assess the pharmacokinetic (PK) profile of two dosing regimens of the pediatric formulation of bosentan in children with pulmonary arterial hypertension (PAH) <12 years of age.
Country
Australia
,
Belarus
,
China
,
Czech Republic
,
France
,
Germany
,
Hungary
,
India
,
Israel
,
Italy
,
Mexico
,
Netherlands
,
Poland
,
Russian Federation
,
Serbia
,
South Africa
,
Spain
,
Ukraine
,
United States
,
organs
None
Specialty
None
Closed trial
More information
1